Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation‐dependent signaling pathways

Fleisch, 2002, Development of bisphosphonates, Breast Cancer Res, 4, 30, 10.1186/bcr414 Rogers, 2003, New insights into the molecular mechanisms of action of bisphosphonates, Curr Pharm Des, 9, 2643, 10.2174/1381612033453640 Zhang, 1996, Protein prenylation: molecular mechanisms and functional consequences, Annu Rev Biochem, 65, 241, 10.1146/annurev.bi.65.070196.001325 Caraglia, 2005, Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications, Curr Drug Targets, 6, 301, 10.2174/1389450053765833 Fournier, 2002, Bisphosphonates inhibit angiogenesis in vitro and testosterone‐stimulated vascular regrowth in the ventral prostate in castrated rats, Cancer Res, 62, 6538 Wood, 2002, Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid, J Pharmacol Exp Ther, 302, 1055, 10.1124/jpet.102.035295 Giraudo, 2004, An amino‐bisphosphonate targets MMP‐9‐expressing macrophages and angiogenesis to impair cervical carcinogenesis, J Clin Invest, 114, 623, 10.1172/JCI200422087 Santini, 2002, Pamidronate induces modifications of circulating angiogenetic factors in cancer patients, Clin Cancer Res, 8, 1080 Santini, 2003, Zoledronic acid induces significant and long‐lasting modifications of circulating angiogenic factors in cancer patients, Clin Cancer Res, 9, 2893 Ferretti, 2005, Zoledronic‐acid‐induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients, Oncology, 69, 35, 10.1159/000087286 Vincenzi, 2005, Zoledronic acid‐related angiogenesis modifications and survival in advanced breast cancer patients, J Interferon Cytokine Res, 25, 144, 10.1089/jir.2005.25.144 Migliorati, 2006, Bisphosphonate‐associated osteonecrosis: a long‐term complication of bisphosphonate treatment, Lancet Oncol, 7, 508, 10.1016/S1470-2045(06)70726-4 Bezzi, 2003, Zoledronate sensitizes endothelial cells to tumor necrosis factor‐induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt, J Biol Chem, 278, 43603, 10.1074/jbc.M308114200 Zhao, 2002, Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox), J Biol Chem, 277, 25385, 10.1074/jbc.M203630200 Hasmim, 2005, Expressed isolated integrin beta1 subunit cytodomain induces endothelial cell death secondary to detachment, Thromb Haemost, 94, 1060, 10.1160/TH05-02-0108 Luckman, 1998, Nitrogen‐containing bisphosphonates inhibit the mevalonate pathway and prevent post‐translational prenylation of GTP‐binding proteins, including Ras, J Bone Miner Res, 13, 581, 10.1359/jbmr.1998.13.4.581 Senaratne, 2002, The bisphosphonate zoledronic acid impairs Ras membrane localisation and induces cytochrome c release in breast cancer cells, Br J Cancer, 86, 1479, 10.1038/sj.bjc.6600297 Reszka, 2001, Nitrogen‐bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation, Mol Pharmacol, 59, 193, 10.1124/mol.59.2.193 Crick, 1997, Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation, Biochem Biophys Res Commun, 237, 483, 10.1006/bbrc.1997.7145 Parsons, 2000, Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement, Oncogene, 19, 5606, 10.1038/sj.onc.1203877 Etienne‐Manneville, 2002, Rho GTPases in cell biology, Nature, 420, 629, 10.1038/nature01148 Holstein, 2002, Consequences of mevalonate depletion. Differential transcriptional, translational, and post‐translational up‐regulation of Ras, Rap1a, RhoA, and RhoB, J Biol Chem, 277, 10678, 10.1074/jbc.M111369200 Johnson, 2002, Mitogen‐activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science, 298, 1911, 10.1126/science.1072682 Galetic, 1999, Mechanism of protein kinase B activation by insulin/insulin‐like growth factor‐1 revealed by specific inhibitors of phosphoinositide 3‐kinase – significance for diabetes and cancer, Pharmacol Ther, 82, 409, 10.1016/S0163-7258(98)00071-0 Marinissen, 2004, The small GTP‐binding protein RhoA regulates c‐jun by a ROCK‐JNK signaling axis, Mol Cell, 14, 29, 10.1016/S1097-2765(04)00153-4 Brazil, 2004, Advances in protein kinase B signalling: AKTion on multiple fronts, Trends Biochem Sci, 29, 233, 10.1016/j.tibs.2004.03.006 Schaller, 2001, Biochemical signals and biological responses elicited by the focal adhesion kinase, Biochim Biophys Acta, 1540, 1, 10.1016/S0167-4889(01)00123-9 Byzova, 2000, A mechanism for modulation of cellular responses to VEGF: activation of the integrins, Mol Cell, 6, 851 Lin, 2003, Activation of the JNK signaling pathway: breaking the brake on apoptosis, Bioessays, 25, 17, 10.1002/bies.10204 Reuther‐Madrid, 2002, The p65/RelA subunit of NF‐kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor, Mol Cell Biol, 22, 8175, 10.1128/MCB.22.23.8175-8183.2002 Kim, 2001, Akt phosphorylates and negatively regulates apoptosis signal‐regulating kinase 1, Mol Cell Biol, 21, 893, 10.1128/MCB.21.3.893-901.2001 Huang, 2003, JNK phosphorylates paxillin and regulates cell migration, Nature, 424, 219, 10.1038/nature01745 Homsy, 2006, JNK signaling coordinates integrin and actin functions during Drosophila embryogenesis, Dev Dyn, 235, 427, 10.1002/dvdy.20649 Huynh‐Do, 2002, Ephrin‐B1 transduces signals to activate integrin‐mediated migration, attachment and angiogenesis, J Cell Sci, 115, 3073, 10.1242/jcs.115.15.3073 Chang, 2003, Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention, Leukemia, 17, 1263, 10.1038/sj.leu.2402945 Graves, 2003, The contribution of interleukin‐1 and tumor necrosis factor to periodontal tissue destruction, J Periodontol, 74, 391, 10.1902/jop.2003.74.3.391